We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Risk of cancer in patients with psoriasis on biological therapies: a systematic review.
- Authors
Peleva, E.; Exton, L. S.; Kelley, K.; Kleyn, C. E.; Mason, K. J.; Smith, C. H.
- Abstract
Summary: Psoriasis is a skin condition that leads to inflammation, resulting in red, scaly skin. Biologic therapies are very powerful treatments for psoriasis, but unfortunately, they have significant effects on the immune system, which may increase the possibility of getting cancers. The authors of this study analysed previous research (until August 2016) that looked at whether patients with psoriasis who received biologic therapies got more cancers compared to other patients. Some studies found that there was an increase in certain types of skin cancers, called non‐melanoma skin cancers (NMSC). There was no increase in any other types of cancers in the studies. However, the authors recognised several weaknesses in the studies, which could have affected the results. More research is needed to know whether there really is an increased risk of skin cancer with biologic treatment. Patients participating in long term studies such as the British Association of Dermatologists Biologic Interventions Register (BADBIR) will help to answer this important question.
- Subjects
RISK factors of skin cancer; PSORIASIS treatment; DERMATOLOGY; CANCER immunology; SYSTEMATIC reviews
- Publication
British Journal of Dermatology, 2018, Vol 178, Issue 1, pe76
- ISSN
0007-0963
- Publication type
Article
- DOI
10.1111/bjd.16188